Co-expression of p53 and MDM2 in human atherosclerosis: Implications for the regulation of cellularity of atherosclerotic lesions

Journal of Pathology

Volumn 185, Issue 3, 1998, Pages 303-312

  Ihling, Christian ^a   Haendeler, Judith ^c   Menzel, Grit ^a   Hess, Ralf D ^a   Fraedrich, Gustav ^b   Schaefer, Hans E ^a   Zeiher, Andreas M ^c  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF INNSBRUCK   (Austria)

^c GOETHE UNIVERSITY   (Germany)

Author keywords

Atherosclerosis; MDM2; P53

Indexed keywords

DNA FRAGMENT; ONCOPROTEIN; PROTEIN P53;

APOPTOSIS; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; INFLAMMATION; MACROPHAGE; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SMOOTH MUSCLE FIBER;

APOPTOSIS; ARTERIOSCLEROSIS; BLOTTING, WESTERN; CAROTID ARTERIES; CELL DIVISION; DNA FRAGMENTATION; FLUORESCENT ANTIBODY TECHNIQUE; GENETIC TECHNIQUES; HUMANS; MACROPHAGES; MUSCLE, SMOOTH, VASCULAR; NUCLEAR PROTEINS; PRECIPITIN TESTS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0031875104     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199807)185:3<303::AID-PATH106>3.0.CO;2-P     Document Type: Article

References (33)

1. Vogelstein B, Kinzler KW. p53 function and dysfunction. Cell 1992; 70: 523-526.
2. Donehower LA, Harvey M, Slagle BL, et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors. Nature 1992; 356: 215-221.
3. Oren M, Maltzmann W, Levine AJ. Post-translational regulation of the 54 K cellular tumor antigen in normal and transformed cells. Mol Cell Biol 1981; 1: 101-110.
4. Fritsche M, Haessler C, Brandner G. Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents. Oncogene 1993; 8: 307-318.
5. Messmer UK, Ankarcrona M, Nicotera P, Brune B. p53 expression in nitric oxide-induced apoptosis. FEBS Lett 1994; 335: 23-26.
6. Schmidt RJ, Siegel J, Haessler G, Brandner G, Hess RD. p53 accumulation elicited by lipopolysaccharide (LPS) combined with Interferon (IFN)-c and by NO-generating agents in L929 cells. J Cancer Res Clin Oncol 1995; 121 (Suppl 2): A12.
7. Cahilly-Snyder L, Yang-Fen T, Francke U, George DL. Molecular analysis and chromosomal mapping of amplified genes isolated from a transformed mouse 3T3 cell line. Somat Cell Mol Genet 1987; 13: 225-244.
8. Oliner JD, Kinzler KW, Meltzer PS, George DL, Vogelstein B. Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 1992; 358: 80-83.
9. Wu X, Bayle JH, Olson D, Levine AJ. The p53-MDM2 autoregulatory feedback loop. Genes Dev 1993; 7: 1126-1132.
10. Haupt Y, Maya R, Kazaz A, Oren M. Mdm2 promotes the rapid degradation of p53. Nature 1997; 387: 296-299.
11. Shieh SY, Ikeda M, Taya Y, Prives C. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 1997; 91: 325-334.
12. Xiao ZX, Chen J, Levine AJ, et al. Interaction between the retinoblastoma protein and the oncoprotein MDM2. Nature 1995; 375: 694-698.
13. Chang MW, Barr E, Lu MM, Barton K, Leiden JM. Adenovirus-mediated overexpression of the cyclin/cyclin-dependent kinase inhibitor p21 inhibits vascular smooth muscle proliferation and neointima formation in the rat carotid artery model of balloon angioplasty. J Clin Invest 1995; 96: 2260-2268.
14. Bennett MR, Littlewood DT, Schwartz SM, Weissberg PL. Increased sensitivity of human vascular smooth muscle cells from atherosclerotic plaques to p53-mediated apoptosis. Circ Res 1997; 81: 591-599.
15. Ross R. The pathogenesis of atherosclerosis: perspective for the 1990s. Nature 1993; 362: 801-809.
16. Iacopetta B, Wysocki S, Norman P, House A. The p53 tumour suppressor gene is overexpressed but not mutated in human atherosclerotic tissue. Int J Oncol 1995; 7: 399-402.
17. Speir E, Modali R, Huang ES, et al. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 1994; 265: 391-394.
18. Johnson TM, Epstein SE, Finkel T. Species specific induction of apoptosis in normal vascular smooth muscle cells using an adenovirus expressing human p53. Circulation 1996; 94: I-155 (Abstract).
19. López-Candales A, Holmes DR, Liao S, Scott MJ, Wickline SA, Thompson RW. Decreased vascular smooth muscle cell density in medial degeneration of abdominal aortic aneurysms. Am J Pathol 1997; 150: 993-1007.
20. Isner JM, Kearney M, Bortmann S, Paseri J. Apoptosis in human atherosclerosis and restenosis. Circulation 1995; 91: 2703-2711.
21. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labelling of nuclear DNA fragmentation. J Cell Biol 1992; 119: 493-501.
22. Ihling C, Menzel G, Wellens E, Schulte Mönting J, Schaefer HE, Zeiher AM. Topographical association between the cyclin-dependent kinase inhibitor P21, p53 accumulation, and cellular proliferation in human atherosclerotic tissue. Arterioscl Thromb Vasc Biol 1997; 17: 2218-2224.
23. Martinez JC, Mateo M, Sanchez-Beato M, et al. MDM2 expression in lymphoid cells and reactive and neoplastic lymphoid tissue. Comparative study with p53 expression. J Pathol 1995; 177: 27-34.
24. Olson DC, Marechal V, Momand J, Chen J, Romocki C, Levine A. Identification and characterization of multiple mdm-2 proteins and mdm-2-p53 protein complexes. Oncogene 1993; 8: 2353-2360.
25. Perry ME, Piette J, Zawadzki JA, Harvey D, Levine AJ. The mdm-2 gene is induced in response to UV light in a p53 dependent manner. Proc Natl Acad Sci USA 1993; 90: 11 623-11 627.
26. Montes de Oca Luna R, Wagner DS, Lozano G. Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature 1995; 378: 203-206.
27. Jones SN, Roe AE, Donehower LA, Bradley A. Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53. Nature 1995; 78: 206-208.
28. Hansson GK, Holm J, Jonasson L. Detection of activated T lymphocytes in human atherosclerotic plaque. Am J Pathol 1989; 135: 169-175.
29. Libby P, Ordovas JM, Berinyi LK, Auger KR, Dinarello CA. Inducible IL-1 gene expression in human vascular smooth muscle cells. J Clin Invest 1986; 78: 1432-1438.
30. Barath P, Fishbein MC, Cao J, Berenson J, Helfant RH, Forrester JS. Detection and localization of tumor necrosis factor in human atheroma. Am J Cardiol 1990; 65: 297-302.
31. Beckmann JS, Beckmann TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and Superoxide. Proc Natl Acad Sci USA 1990; 87: 1620-1624.
32. Kuwano K, Hagimoto N, Nomoto Y, et al. P53 and p21 (Waf1/Cip1) mRNA expression associated with DNA damage and repair in acute immune complex alveolitis in mice. Lab Invest 1997; 76: 161-169.
33. Antoniades HN, Galanopoulos T, Nevile-Golden J, Kiritsy CP, Lynch SM. P53 expression during normal tissue regeneration in response to acute cutaneous injury in swine. J Clin Invest 1994; 93: 2206-2214.